Oncological and reproductive outcomes following fertility-preserving treatment in mismatch repair-deficient endometrial cancer or atypical endometrial hyperplasia

Tianyu Zhang, Jie Yang, Dongyan Cao, Mei Yu, Huanwen Wu, Yang Xiang, Xinyue Zhang, Xuan Zong, Rundong Zhang, Xinyang Jin, Kezhen Zhang, Jing Zheng, Jiaxin Yang · 2026

Read Oncological and reproductive outcomes following fertility-preserving treatment in mismatch repair-deficient endometrial cancer or atypical endometrial hyperplasia by Tianyu Zhang, Jie Yang, Dongyan Cao, Mei Yu, Huanwen Wu, Yang Xiang, Xinyue Zhang, Xuan Zong, Rundong Zhang, Xinyang Jin, Kezhen Zhang, Jing Zheng, Jiaxin Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13393862.txt.

Description

Tianyu Zhang and colleagues track cancer and pregnancy outcomes after fertility-preserving treatment for mismatch repair-deficient endometrial disease in a 2026 study. Young patients with this molecular subtype may wish to keep fertility, but management guidance was thin.

Fourteen patients treated at Peking Union Medical College Hospital from 2020 to 2023 were reviewed, with a mean diagnosis age near 34. Loss of MLH1 and PMS2 proteins was the most common pattern, and germline variants appeared in three of twelve tested patients. Follow-up over a median of about 35 months informs how safely fertility can be preserved in this group.

Catalog record

CREATORTianyu Zhang, Jie Yang, Dongyan Cao, Mei Yu, Huanwen Wu, Yang Xiang, Xinyue Zhang, Xuan Zong, Rundong Zhang, Xinyang Jin, Kezhen Zhang, Jing Zheng, Jiaxin Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13393862

Browse the full library · About the Tower of Babel